Filter by:

Reset Filter
  • Antitrust and Competition
Showing 13 - 24 of 108
Case

In the Matter of US Foods and Services Group of America

The FTC ordered US Foods to divest certain assets to complete its acquisition of SGA.

Case

In the Matter of Aveanna Healthcare LLC and Maxim Healthcare Services

The FTC closed its investigation into this proposed merger after the parties abandoned the transaction.

Case

In the Matter of Edgewell Personal Care Company and Harry’s Inc.

In February 2020, the Federal Trade Commission dismissed its lawsuit after the parties decided not to pursue the merger.

Case

In the Matter of Walgreens Boots Alliance and Rite Aid

The FTC retained Cornerstone Research in its review of this proposed merger.

Case

In the Matter of Ball Corporation and Rexam PLC

The FTC ordered Ball Corporation to divest eight U.S. aluminum can plants in order to proceed with its acquisition of Rexam PLC.

Case

Fresenius Kabi USA LLC v. Par Sterile Products LLC et al.

Our client’s motion for summary judgment was granted in this pharmaceutical antitrust matter involving allegations of market foreclosure.

Case

In re Niaspan Antitrust Litigation

The judge denied class certification in this pharmaceutical pay-for-delay multidistrict litigation.

Case

Federal Communications Commission Proceedings

Cornerstone Research provided economic consulting in FCC proceedings related to competition in mobile wireless, broadband services, and special access services provided by local exchange carriers.

Case

T-Mobile/Sprint Merger Approved

Counsel for SoftBank and Sprint Corporation retained Cornerstone Research to assist with the regulatory review of T-Mobile’s $26 billion merger with Sprint.

Case

In re Intuniv Antitrust Litigation

The judge denied class certification in this pharmaceutical pay-for-delay case brought by a class of indirect purchasers.

Case

Alleged Price Discrimination and Unfair Competition among Automobile Dealerships

Professor Asker submitted expert testimony on behalf of a major automobile manufacturer.

Case

Cigna’s Acquisition of Express Scripts

The parties completed a $67 billion merger after receiving clearance from the U.S. Department of Justice and state departments of insurance.

How can we help you?

If you are looking for additional case experience examples, contact us.